02.12.2012 Views

Annual Report 2010/11 - Sonova

Annual Report 2010/11 - Sonova

Annual Report 2010/11 - Sonova

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

6<br />

<strong>Sonova</strong> Group<br />

<strong>Sonova</strong> – the hearing care company<br />

<strong>Sonova</strong> Holding AG develops, manufactures and distributes solutions for better<br />

hearing. With its comprehensive technological expertise, its extensive brand<br />

and product portfolio and its global distribution presence, <strong>Sonova</strong> is in an excellent<br />

position to serve the fast-growing market for hearing-related products.<br />

The <strong>Sonova</strong> Group, which was formed from Phonak Holding<br />

AG on August 1, 2007, has over 60 years of experience in<br />

hearing technology. The current portfolio includes hearing<br />

systems distributed under the Phonak, Unitron, Lyric, and<br />

Sona brands; implant solutions from Advanced Bionics and<br />

Phonak Acoustic Implants; wireless communication and<br />

radio technologies, and hearing protection solutions from<br />

Phonak Communications.<br />

SONOVA AT A GLANCE – KEY FIGURES FOR <strong>2010</strong>/20<strong>11</strong><br />

— EBITA: CHF 326.6 million<br />

— EBITA margin: 20.2%<br />

— Cash-based basic earnings<br />

per share: CHF 4.27<br />

— Operating free cash flow: CHF 221.5 million<br />

90<br />

countries –<br />

worldwide presence<br />

As the industry’s technology leader, <strong>Sonova</strong> has more than<br />

7,800 employees and works daily to help people throughout<br />

the world hear better and enjoy a higher quality of life.<br />

With investments of CHF 107 million in research and development<br />

in the <strong>2010</strong>/20<strong>11</strong> financial year, <strong>Sonova</strong> has made<br />

a commitment to innovation over the long term.<br />

With a comprehensive portfolio and a strategic focus on<br />

core competencies, the Group plans to further increase<br />

its sales and EBITA margin in the coming years and to grow<br />

faster than the market.<br />

1.617<br />

Sales in CHF billion<br />

— ROCE: 19.0%<br />

— ROE: 17.7%

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!